Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | ACLY | P53396 | 1/20 | 0.38 |
| ▸ | VDR | P11473 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.34 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL40405 | 0.89 | MAPT (0.41) | NPC1MAPTRAB9AACLYVDR | |
| SCHEMBL13823374 | 0.83 | ALDH1A1 (0.38) | NPC1MAPTRAB9AACLYVDR | |
| SCHEMBL13169002 | 0.83 | MAPT (0.37) | NPC1MAPTRAB9AACLYVDR | |
| SCHEMBL40426 | 0.82 | RAB9A (0.38) | NPC1MAPTRAB9AACLYVDR | |
| SCHEMBL14694381 | 0.80 | MAPT (0.41) | NPC1MAPTRAB9AACLYVDR | |
| SCHEMBL803057 | 0.80 | MAPT (0.41) | NPC1MAPTRAB9AACLYVDR | |
| SCHEMBL17703322 | 0.80 | MAPT (0.41) | NPC1MAPTRAB9AACLYVDR | |
| SCHEMBL22590645 | 0.80 | NPC1 (0.35) | NPC1MAPTRAB9AACLYVDR | |
| SCHEMBL17902936 | 0.79 | OXTR (0.40) | NPC1MAPTRAB9AACLYVDR | |
| SCHEMBL12066845 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120029116-A1 | CURABLE ADHESIVE COMPOSITIONS, PROCESS, AND APPLICATIONS | TRILLION SCIENCE, INC. (US) | 2012-02-02 | — | — | US | disclosed |
| US-20120029116-A1 | CURABLE ADHESIVE COMPOSITIONS, PROCESS, AND APPLICATIONS | TRILLION SCIENCE, INC. (US) | 2012-02-02 | — | — | US | disclosed |
| US-8084553-B2 | Curable adhesive compositions, process, and applications | TRILLION SCIENCE, INC. (US) | 2011-12-27 | — | — | US | disclosed |
| US-8084553-B2 | Curable adhesive compositions, process, and applications | TRILLION SCIENCE, INC. (US) | 2011-12-27 | — | — | US | disclosed |
| US-20090181165-A1 | Curable adhesive compositions, Process, and applications | TRILLION SCIENCE, INC. (US) | 2009-07-16 | — | — | US | disclosed |
| US-20090181165-A1 | Curable adhesive compositions, Process, and applications | TRILLION SCIENCE, INC. (US) | 2009-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029116-A1 | CURABLE ADHESIVE COMPOSITIONS, PROCESS, AND APPLICATIONS | RBX1, SUZ12, CDH1 | NPC1 4850/4885MAPT 547/4885RAB9A 4443/4885 |
| US-20090181165-A1 | Curable adhesive compositions, Process, and applications | RBX1, SUZ12, CDH1 | NPC1 4850/4885MAPT 547/4885RAB9A 4443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.